TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing October 8, 2010
TCL Archive House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments August 4, 1995
